Newin vitroandin vivomodels to evaluate antibiotic efficacy inStaphylococcus aureusprosthetic vascular graft infection | Zendy

Matthieu Revest | Zendy; Cédric Jacqueline | Zendy; Rym Boudjemaa | Zendy; J. Caillon | Zendy; V. Le Mabecque | Zendy; Anne Bretéché | Zendy; Karine Steenkeste | Zendy; Pierre Tattevin | Zendy; G. Potel | Zendy; C. Michelet | Zendy; M.-P. Fontaine-Aupart | Zendy; D. Boutoille | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Newin vitroandin vivomodels to evaluate antibiotic efficacy inStaphylococcus aureusprosthetic vascular graft infection

Author(s) -

Matthieu Revest,

Cédric Jacqueline,

Rym Boudjemaa,

J. Caillon,

V. Le Mabecque,

Anne Bretéché,

Karine Steenkeste,

Pierre Tattevin,

G. Potel,

C. Michelet,

M.-P. Fontaine-Aupart,

D. Boutoille

Publication year - 2016

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkv496

Subject(s) - daptomycin , cloxacillin , antibiotics , microbiology and biotechnology , staphylococcus aureus , vancomycin , rifampicin , in vivo , medicine , biofilm , minimum inhibitory concentration , fusidic acid , biology , bacteria , penicillin , genetics

Prosthetic vascular graft infection (PVGI) is an emerging disease, mostly caused by staphylococci, with limited data regarding efficacy of current antistaphylococcal agents. We aimed to assess the efficacy of different antibiotic regimens.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research